Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Infez Med ; 29(1): 20-36, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33664170

ABSTRACT

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. COVID-19 pandemic has overburdened healthcare systems in most countries and has led to massive economic losses. SARS-CoV-2 transmission typically occurs by respiratory droplets. The average incubation period is 6.4 days and presenting symptoms typically include fever, cough, dyspnea, myalgia or fatigue. While the majority of patients tend to have a mild illness, a minority of patients develop severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly supportive. However, several direct anti-viral agents, and immunomodulatory therapy with steroids and various cytokine blockers seem promising in early results. However, an effective vaccine has been established, which will help curb the pandemic.


Subject(s)
COVID-19 , Global Health/statistics & numerical data , Pandemics , SARS-CoV-2/pathogenicity , Adrenal Cortex Hormones/therapeutic use , Air Microbiology , Antiviral Agents/therapeutic use , COVID-19/complications , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/therapy , COVID-19 Testing/methods , COVID-19 Vaccines/therapeutic use , Disease Transmission, Infectious , Hospitalization , Humans , Hypoxia/etiology , Hypoxia/therapy , Immunization, Passive , Immunologic Factors/therapeutic use , Infectious Disease Incubation Period , Primary Prevention/methods , Respiration, Artificial , SARS-CoV-2/classification , SARS-CoV-2/genetics , Steroids/therapeutic use , Symptom Assessment/methods , COVID-19 Serotherapy
SELECTION OF CITATIONS
SEARCH DETAIL
...